| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35573-459-60 | 35573-459 | HUMAN PRESCRIPTION DRUG | Carglumic acid | Carglumic acid | TABLET, FOR SUSPENSION | ORAL | 20221219 | N/A | ANDA | ANDA213395 | Burel Pharmaceuticals, LLC | CARGLUMIC ACID | 200 mg/1 | 60 TABLET, FOR SUSPENSION in 1 BOTTLE (35573-459-60) |
| 68475-006-01 | 68475-006 | HUMAN PRESCRIPTION DRUG | Carglumic acid | Carglumic acid | TABLET, FOR SUSPENSION | ORAL | 20220801 | N/A | ANDA | ANDA213395 | Navinta LLC | CARGLUMIC ACID | 200 mg/1 | 5 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-01) |
| 68475-006-02 | 68475-006 | HUMAN PRESCRIPTION DRUG | Carglumic acid | Carglumic acid | TABLET, FOR SUSPENSION | ORAL | 20220801 | N/A | ANDA | ANDA213395 | Navinta LLC | CARGLUMIC ACID | 200 mg/1 | 60 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-02) |